# DCB for CAD With Type 2 Diabetes

Study · id `cardio:ct-nct07009938` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07009938](<https://clinicaltrials.gov/study/NCT07009938>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07009938

Browse, organ or system: Heart; Metabolism  
Browse, condition area: Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT07009938. Randomized; single masking; primary purpose treatment. Start 2025-07-01 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT07009938, source copy `cardio:ctgov-nct07009938-2025-06-08`, retrieved 2026-10-26)
- Planned start: 2025-07-01 (anticipated) (ClinicalTrials.gov record NCT07009938, source copy `cardio:ctgov-nct07009938-2025-06-08`, retrieved 2026-10-26)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07009938, source copy `cardio:ctgov-nct07009938-2025-06-08`, retrieved 2026-10-26)
- Completion: 2028-07-01 (anticipated) (ClinicalTrials.gov record NCT07009938, source copy `cardio:ctgov-nct07009938-2025-06-08`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07009938, source copy `cardio:ctgov-nct07009938-2025-06-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07009938-2025-06-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: DCB for CAD With Type 2 Diabetes
- Acronym: DCBinT2DM
- Condition: Coronary Artery Disease
- Condition: Diabete Type 2
- Intervention (Device): Drug-Coated Balloon (DCB)
- Intervention (Device): Drug-Eluting Stent (DES) implantation
- Lead sponsor: Shanghai 10th People's Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Shanghai 10th People's Hospital (`cardio:org-shanghai-10th-people-s-hospital`)

## Provenance

Content hash: 2554645f3b6d8136fab3375d397046198dcd5c15170f845ab00be0d5e6d8412a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
